ECCO2017: European Cancer Congress

login
My congress planner

Abstract Submission

ECCO2017

ECCO2017 Abstract Submission

Abstract submission is now CLOSED

Abstract submission deadline: 7 December 2016, 21:00 CET

Authors are strongly advised to submit prior to the deadline and avoid unnecessary delays which may affect the standing of their abstract.

The European Cancer Congress is the platform for presenting ground-breaking data to a global audience.  The Congress is highly anticipated by scientific journals, all specialized media and titles of broader public appeal.  A solid media strategy is in place to ensure timely and optimal dissemination of scientific news announced at ECCO2017.  Worldwide scientific media coverage is assured for exciting new data.

Abstracts submitted for presentation in the European Cancer Congress will be reviewed by an international panel of experts in the field of the subject and will be judged solely on the data submitted. The final decision on the presentation format of all selected abstracts is at the sole discretion of the Scientific Committee.

Late-Breaking Abstract Submission

Abstract submission is now CLOSED

Abstract submission deadline: 7 December 2016, 21:00 CET

Late-breaking abstracts describe the latest advances that will change our daily clinical practice. They should highlight novel and practice-changing studies. Focus is placed on capturing abstracts with ground-breaking and unique data that would have been presented for the first time.

Examples of suitable late-breaking abstracts might include the results of a practice-changing prospective Phase III clinical trial; a Phase II study showing anti-tumour activity in a novel context – in each case the results should not have been fully available by the regular abstract submission deadline.

In case of any abstract related queries please contact: programme@ecco-org.eu

PRINT THIS PAGE Page last modified: